CEA
Ƙimar Ganewa: ≤ 1.0 ng/ml;
Matsakaicin iyaka: 1-500 ng/ml;
Matsakaicin daidaituwa na layi R ≥ 0.990;
Daidaitawa: a cikin tsari CV shine ≤ 15%;tsakanin batches CV shine ≤ 20%;
Daidaito: karkatar da sakamakon ma'aunin dangi bazai wuce ± 15% ba lokacin da aka gwada ma'aunin daidaitaccen ma'aunin CEA na ƙasa ko daidaitaccen ma'aunin ƙididdiga.
1. Ajiye ma'aunin ganowa a 2～30℃.Matsakaicin ya tsaya tsayin daka har zuwa watanni 18.
2. Adana kaset ɗin gwajin sauri na Aehealth Ferritin a 2～30 ℃, rayuwar rayuwar ta kasance har zuwa watanni 18.
3. Ya kamata a yi amfani da kaset na gwaji a cikin awa 1 bayan buɗe fakitin.
CEA (Carcinoembryonic Antigen), sel-surface 200 KD glycoprotein, yawanci ana samarwa yayin haɓakar tayin amma yana ɓacewa ko kuma ya zama ƙasa sosai a cikin jinin manya masu lafiya saboda haɗin wannan furotin yana ƙarewa kafin haihuwa.Duk da haka, ƙara yawan matakan zai iya kasancewa a cikin launi, yanki na ciki, nono, ovary, hanta, huhu, pancreas, biliary da medullary thyroid carcinoma, da kuma a wasu yanayi mara kyau kamar shan taba, cututtukan hanji mai kumburi, gastritis na kullum, peptic ulcer, cirrhosis. , hepatitis da pancreatitis.Ana amfani da CEA sau da yawa don saka idanu ga marasa lafiya da ciwon daji, musamman carcinoma mai launi, bayan tiyata don auna amsawar jiyya da kuma ko cutar ta sake dawowa.Lokacin da matakin CEA ya yi girma sosai kafin tiyata ko wasu jiyya, ana sa ran komawa ga al'ada bayan bin nasarar tiyata don cire ciwon daji.Hawan matakin CEA yana nuna ci gaba ko dawowar cutar kansa.